Page last updated: 2024-10-19

oxaloacetic acid and Glial Cell Tumors

oxaloacetic acid has been researched along with Glial Cell Tumors in 1 studies

Oxaloacetic Acid: A dicarboxylic acid ketone that is an important metabolic intermediate of the CITRIC ACID CYCLE. It can be converted to ASPARTIC ACID by ASPARTATE TRANSAMINASE.
oxaloacetic acid : An oxodicarboxylic acid that is succinic acid bearing a single oxo group.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ruban, A	1
Berkutzki, T	1
Cooper, I	1
Mohar, B	1
Teichberg, VI	1

Clinical Trials (4)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Role of Glutamate-mediate Excitotoxicity in Invasion and Progression Processes of Glioblastoma Multiforme[NCT05775458]		50 participants (Anticipated)	Observational	2020-06-01	Recruiting
Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors[NCT04592354]		40 participants (Anticipated)	Interventional	2020-10-15	Recruiting
A Phase 2, Randomized, Open-Label Study of Anhydrous Enol-Oxaloacetate in Subjects With Newly Diagnosed Glioblastoma Multiforme[NCT04450160]	Phase 2	80 participants (Anticipated)	Interventional	2020-12-31	Not yet recruiting
A Randomized Double Blind Placebo Controlled Trial to Determine the Effects of Oxaloacetate on Improving Fatigue in ME/CFS[NCT05273372]		80 participants (Anticipated)	Interventional	2022-03-15	Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for oxaloacetic acid and Glial Cell Tumors

Article	Year
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cel	2012